Byrd; John C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Byrd; John C..The latest application filed is for "methods and compositions for inhibition of dihydroorotate dehydrogenase".

Company Profile

5.17.25

Byrd; John C. - Columbus OH
Byrd; John C. - Arlington OH
BYRD, JOHN C. - BETHESDA MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for inhibition of dihydroorotate dehydrogenase Grant 11,312,686 - Byrd , et al. April 26, 2	2022-04-26
Methods And Compositions For Inhibition Of Dihydroorotate Dehydrogenase App 20220064119 - BYRD; John C. ; et al.	2022-03-03
Methods And Compositions For Inhibition Of Dihydroorotate Dehydrogenase App 20210253531 - BYRD; John C. ; et al.	2021-08-19
Methods Of Treating And Preventing Graft Versus Host Disease App 20210121463 - Byrd; John C. ; et al.	2021-04-29
Methods of treating and preventing graft versus host disease Grant 10,695,350 - Byrd , et al.	2020-06-30
Tec Family Kinase Inhibitor Adjuvant Therapy App 20200147084 - Buggy; Joseph J. ; et al.	2020-05-14
Methods Of Treating And Preventing Graft Versus Host Disease App 20200009148 - Byrd; John C. ; et al.	2020-01-09
Methods of treating and preventing graft versus host disease Grant 10,463,668 - Byrd , et al. No	2019-11-05
Phospholipase C Gamma 2 And Resistance Associated Mutations App 20190203297 - Byrd; John C. ; et al.	2019-07-04
Methods Of Treating And Preventing Graft Versus Host Disease App 20180078555 - Byrd; John C. ; et al.	2018-03-22
Tec Family Kinase Inhibitor Adjuvant Therapy App 20180071293 - Buggy; Joseph J. ; et al.	2018-03-15
Phospholipase C gamma 2 and resistance associated mutations Grant 9,885,086 - Byrd , et al. February 6, 2	2018-02-06
Methods of treating and preventing graft versus host disease Grant 9,795,604 - Byrd , et al. October 24, 2	2017-10-24
TEC family kinase inhibitor adjuvant therapy Grant 9,717,731 - Buggy , et al. August 1, 2	2017-08-01
Biomarker For Predicting Response Of Cll To Treatment With A Btk Inhibitor App 20150361504 - BYRD; John C. ; et al.	2015-12-17
Phospholipase C Gamma 2 And Resistance Associated Mutations App 20150267261 - BYRD; John C. ; et al.	2015-09-24
Compositions and methods for increasing drug efficacy in cancer Grant 9,044,474 - Byrd , et al. June 2, 2	2015-06-02
Methods Of Treating And Preventing Graft Versus Host Disease App 20150118209 - BYRD; John C. ; et al.	2015-04-30
Tec Family Kinase Inhibitor Adjuvant Therapy App 20140371241 - BUGGY; Joseph J. ; et al.	2014-12-18
Anti-CD74 immunoconjugates and methods of use Grant 8,846,002 - Byrd , et al. September 30, 2	2014-09-30
Tec Family Kinase Inhibitor Adjuvant Therapy App 20140134265 - BUGGY; Joseph J. ; et al.	2014-05-15
Therapeutic agents for the treatment of leukemia Grant 8,633,161 - Perrotti , et al. January 21, 2	2014-01-21
Compositions and Methods for Increasing Drug Efficacy in Cancer App 20140005250 - Byrd; John C. ; et al.	2014-01-02
Anti-CD74 Immunoconjugates and Methods of Use App 20130142729 - Byrd; John C. ; et al.	2013-06-06
Therapeutic Agents for the Treatment of Lymphoid Malignancies App 20130123366 - Byrd; John C. ; et al.	2013-05-16
Anti-CD74 immunoconjugates and methods of use Grant 8,367,037 - Byrd , et al. February 5, 2	2013-02-05
Therapeutic agents for the treatment of lymphoid malignancies Grant 8,318,812 - Byrd , et al. November 27, 2	2012-11-27
FTY720-derived anticancer agents Grant 8,309,768 - Chen , et al. November 13, 2	2012-11-13
Fty720-derived Anticancer Agents App 20120136063 - Chen; Ching-Shih ; et al.	2012-05-31
Anti-CD74 Immunoconjugates and Methods of Use App 20120100068 - Byrd; John C. ; et al.	2012-04-26
Anti-CD74 immunoconjugates and methods of use Grant 8,119,101 - Byrd , et al. February 21, 2	2012-02-21
Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders App 20110280913 - Byrd; John C. ; et al.	2011-11-17
Hybridization Quantitation Method for Modified Micro-RNA and -DNA Based Oligonucleotides App 20110027798 - Chan; Kenneth K. ; et al.	2011-02-03
Anti-CD74 Immunoconjugates and Methods of Use App 20100272636 - Byrd; John C. ; et al.	2010-10-28
Therapeutic Agents For The Treatment Of Leukemia App 20100256072 - Perrotti; Danilo ; et al.	2010-10-07
Therapeutic Agents For The Treatment Of Lymphoid Malignancies App 20100022655 - Byrd; John C. ; et al.	2010-01-28
Treatment of patients with chronic lymphocytic leukemia Grant 6,841,565 - Lucas , et al. January 11, 2	2005-01-11
Combination Therapy For Lymphoproliferative Diseases App 20010006974 - BYRD, JOHN C. ; et al.	2001-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.